Transcript

People with Parkinson’s Need You to Be Aware in Care Joan Gardner RN BSN Nurse Clinician, Clinic Supervisor Struthers Parkinson’s Center Minneapolis, MN

A National Parkinson Foundation Center of Excellence

Parkinson’s Disease Care in the Assisted Living Care Setting

▶  The launch of the National Parkinson Foundation (NPF) Aware in Care Program has helped raise awareness of the unique care needs of the hospitalized patient with Parkinson’s disease (PD) –  Lack of understanding regarding

medication management in PD –  Lack of understanding of contraindicated

medications for those with PD ▶  Information learned from the hospital

Aware in Care program can be transferred to care gaps in the Assisted Living care setting

The Aware in Care toolkit ▶  Helps patients and families advocate for themselves

–  Understand the risks associated with hospital stays –  Be prepared in case you have to go to the hospital—whether

planned or unplanned –  Develop strategies to get better care in the hospital

▶  Draws attention to the high rate of complications when PD pills are not given on time

•  3 out of 4 people with Parkinson’s disease do not receive medications on time in the hospital

•  61% of patients who did not get their medications on time had serious complications from it

Primary Problems of PD Care Management

▶  Lack of understanding of Parkinson’s disease – symptoms, treatment, etc.

▶  Lack of awareness about the critical importance of Parkinson’s medication timing

▶  Lack of awareness that many common medications for pain, nausea, depression, and psychosis are unsafe for people with Parkinson’s

▶  Hospital pharmacies that do not stock the full array of PD medications

▶  Lack of awareness that poorly-managed PD might result in mental confusion and other serious symptoms

Parkinson's Disease in the Assisted Living Setting

▶  Nursing staff and direct care staff may not have much experience with PD residents

▶  Staffing shortages and/or staffing cuts - little time to invest in education

▶  If education occurs, usually is focused on the nursing staff, not on direct care staff

▶  Any knowledge taught is lost with frequent staff turnover

Importance of Care Staff to be Aware in Care

▶  Incidence of PD is expected to double by 2030 –  Increasing longevity of Americans with better

management of chronic conditions of middle-age such as diabetes, hypertension, high cholesterol, etc.

▶  Many with Parkinson’s will need to leave their home due to need of hands-on care as PD symptoms progress

Primary Problems of PD Care Management

▶  Lack of understanding of Parkinson’s disease – symptoms, treatment, etc.

▶  Lack of awareness about the critical importance of Parkinson’s medication timing

▶  Lack of awareness that many common medications for pain, nausea, depression, and psychosis are unsafe for people with Parkinson’s

▶  Hospital pharmacies that do not stock the full array of PD medications

▶  Lack of awareness that poorly-managed PD might result in mental confusion and other serious symptoms

▶  Parkinson’s disease (PD) is a chronic progressive neurological disorder caused by loss of dopamine producing cells in the brain –  Gradual onset, not everyone has all the features

▶  Multiple causes/precipitants –  Rarely genetic, rarely clearly environmental

▶  Predictable course, within reason ▶  Rate of progression and symptoms variable

from person to person ▶  No cure (yet), but symptoms are treatable

What is Parkinson’s disease?

Potential Motor and Non-motor Symptoms of Parkinson’s

Tremor

Bradykinesia

Rigidity

Postural instability and falling

• Depression    • Anxiety    • Lack  of  facial  expression    • Low  voice  volume  or  muffled  speech    • Orthosta<c  hypotension    • Cons<pa<on    • Urinary  dysfunc<on    • Cogni<ve  decline  and  demen<a    • Pain    • Hallucina<ons  and  psychosis    • Sleep  disturbances    • Decreased  ability  to  swallow  (dysphagia)  

Motor  Symptoms                                                                          Non-­‐motor  Symptoms  

Olanow,  2005  Fahn,  2005  

Hoehn & Yahr: Parkinsonism: Onset, progression and mortality. Neurology, 17 (6), 427., May 1967

Parkinson’s Disease - Staging

Stage I: Unilateral involvement

Stage II: Bilateral or Axial involvement without balance impairment

Stage III: Bilateral involvement Mild postural imbalance Patient leads independent life

Stage IV: Bilateral involvement Postural instability Patient requires help with activities of daily living

Stage V: Fully developed disease Patient restricted to bed or chair

Treatment Options

▶  Medication

▶  Surgery

▶  Rehabilitation therapies

▶  Complementary therapies

Treatment Options in Parkinson’s

▶ 

L-­‐Dopa   Dopamine  Agonist  

MAO-­‐B  Inhibitors  

An@-­‐cholinergics  

COMT  Inhibitors  

Other  

 carbidopa/  levodopa  (Sinemet®  or  (Sinemet  CR®)    

carbidopa/  levodopa  oral  disintegra<ng  (Parcopa®)    

carbidopa/  levodopa/  entacapone  (Stalevo®)    

carbidopa/levodopa  ER  (Rytary)  

Carbidopa/levodopa  enteric  gel  (Duopa)  

 ropinirole  (Requip®)    

pramipexole  (Mirapex®)    

ro<go<ne  (Neupro®)    

apomorphine  (Apokyn®)      

 rasagiline  (Azilect®)    selegiline  (l-­‐deprenyl,  Eldepryl®)    zydis  selegiline  HCL  Oral  disintegra<ng  (Zelapar®)      

trihexyphenidyl  (formerly  Artane®)    benztropine    

(Cogen<n®)    ethopropazine  (Parsitan®)      

entacapone  (Comtan®)    

tolcapone  (Tasmar®)    

carbidopa/  levodopa/  entacapone  (Stalevo®)  *has  L-­‐DOPA  in  formula4on      

amantadine  (Symadine®,  Symmetrel®)

• Deep Brain Stimulation surgery

• Medications

• Rehab Therapies

Medication Management of Parkinson’s Disease

Goal of medication treatment is to:

• Increase dopamine levels in the brain

• Improve symptoms of Parkinson’s

• Minimize medication side effects

Carbidopa/Levodopa

▶  By mid-late stage PD, almost all with PD are taking some form of carbidopa/levodopa

▶  Levodopa converts to dopamine in the brain ▶  Carbidopa is a buffer for nausea ▶  Available in

–  immediate release formulation –  immediate release orally disintegrating tablet –  controlled or long acting formulation –  New capsule of IR and CR “beads” in a 1:4 ratio –  New levodopa gel delivered through an intestinal

infusion pump

Protein and Levodopa

▶  Potential for interference of dietary protein with absorption of levodopa –  Would notice a decrease or lack of levodopa

effectiveness when taken too close to a protein meal

▶  A major issue for some

▶  For best effectiveness, take levodopa –  30-60 minutes before you eat –  2 hours after

Difficult to achieve with frequent levodopa dosing

Medication Management in Parkinson’s:

▶  Each medication is scheduled when it is expected to provide the best control of symptoms –  Medication schedules vary from person to person –  May be simple of complex based on symptoms and stage

of disease ▶  As Parkinson’s symptoms progress, and medication

effectiveness changes, medications need to be adjusted over time.

▶  Medications need to be taken frequently through the day and sometimes at night

Motor Fluctuations and Pills on Time

▶  Over time, the duration of the effect of a dose of levodopa becomes shorter

▶  Increase dependence on administration of medication on time in order to be able to move

▶  Patients abilities may change at different times of the day, depending on medication levels –  “ON” –Medications are working well. PD symptoms reduced. –  “OFF”-PD Symptoms coming back –  “Dyskinesia”-Involuntary twisting movements. A side effect of levodopa.

▶  Important for staff to understand what on/off looks like for each individual.

Care Considerations

▶  If PD patients are “OFF”. . . –  At risk for falls because of impaired mobility –  Trouble with fine motor skills, such as eating, toileting –  Slowness in movement and thinking –  Delayed response to questions –  Need more assistance from staff

▶  If PD patients are “ON”. . . –  Less rigidity, tremor, slowness –  Better mobility –  Improved thinking and response to questions

Often misconstrued as stubborn, manipulative, or attention-seeking behavior

Fluctuations  On                                                          Off    

Primary Problems of PD Care Management

▶  Lack of understanding of Parkinson’s disease – symptoms, treatment, etc.

▶  Lack of awareness about the critical importance of Parkinson’s medication timing

▶  Lack of awareness that many common medications for pain, nausea, depression, and psychosis are unsafe for people with Parkinson’s

▶  Hospital pharmacies that do not stock the full array of PD medications

▶  Lack of awareness that poorly-managed PD might result in mental confusion and other serious symptoms

Medication Management in Parkinson’s: The importance of pills on time

–  Important for optimal functioning. Pills taken according to a schedule to help stay ahead of symptoms

–  If medications are taken late, PD symptoms may be more difficult to control

•  For some, 15 minutes late may cause symptoms to increase •  May have an entire “bad” or “off” day if medications are late

–  May lead to social isolation as they are afraid of being “off” in public

Pills on Time Everytime

▶  Nurses have a window for administering medications as a compromise for busy nursing staff who care for multiple patients

▶  As a result, PD residents will receive their medications at seemingly random times

▶  Standard policy for “on time” administration of pills 1 hour before or after prescribed time does not work well for individuals with PD.

▶  Need intentional process for keeping pills on time ▶  Need awareness and plan for pill doses if resident is

away from their room

Primary Problems of PD Care Management

▶  Lack of understanding of Parkinson’s disease – symptoms, treatment, etc.

▶  Lack of awareness about the critical importance of Parkinson’s medication timing

▶  Lack of awareness that many common medications for pain, nausea, depression, and psychosis are unsafe for people with Parkinson’s

▶  Hospital pharmacies that do not stock the full array of PD medications

▶  Lack of awareness that poorly-managed PD might result in mental confusion and other serious symptoms

Contraindicated Medications for PD Medical  Purpose   Safe  Medica@ons   Medica@ons  to  Avoid  

An@psycho@cs   que<apine  (Seroquel®),  clozapine  (Clozaril®).    These  drugs  minimally  affect  Parkinson  symptoms.      

avoid  all  other  typical  and  atypical  an<-­‐psycho<cs,  such  as  haloperidol  (Haldol®)  

Pain  Medica@on   most  are  safe  to  use,  but  narco<c  medica<ons  may  cause  confusion/  psychosis  and  cons<pa<on      

if  pa<ent  is  taking  MAOB  inhibitor  such  as  selegiline  or  rasagiline  (Azilect®),  avoid  meperidine  (Demerol®)    

Nausea/  GI  Drugs    domperidone  (Mo<lium®),  trimethobenzamide  (Tigan®),  ondansetron  (Zofran®),  dolasetron  (Anzemet®),  granisetron  (Kytril®)    

prochlormethazine  (Compazine®),  metoclopramide  (Reglan®),  promethazine  (Phenergan®),  droperidol  (Inapsine®),    as  they  can  worsen  Parkinson  symptoms  

Surgery for Parkinson’s: Deep Brain Stimulation (DBS)

▶  Not an initial therapy, but may be an option when medications do not adequately control the symptoms

▶  Reduces tremor, slowness, rigidity, dystonia, and dyskinesia on the opposite side of the body

▶  Does not help with balance, falls, memory, or non-motor symptoms

▶  Not a cure ▶  Does not stop disease progression ▶  Well-tolerated and can be done on both

sides of the brain

▶  Physical Stressors

▶ a cold or flu ▶  illness ▶  infection ▶ surgery ▶  injury

▶ Emotional Stressors

▶ anxiety ▶ worry ▶ feeling rushed ▶ feeling angry or

upset

Stress has a negative impact on all symptoms of Parkinson’s disease

Primary Problems of PD Care Management

▶  Lack of understanding of Parkinson’s disease – symptoms, treatment, etc.

▶  Lack of awareness about the critical importance of Parkinson’s medication timing

▶  Lack of awareness that many common medications for pain, nausea, depression, and psychosis are unsafe for people with Parkinson’s

▶  Pharmacies that do not stock the full array of PD medications

▶  Lack of awareness that poorly-managed PD might result in mental confusion and other serious symptoms

▶  Levodopa – almost all patients respond ▶  Converts to dopamine in the brain

–  Immediate release carbidopa-levodopa •  10/100, 25/100, 25/250

–  Controlled (extended) release carbidopa-levodopa •  25/100, 50/200

–  Oral dissolving •  Parcopa 10/100, 25/100, 25/250

–  With entacapone •  Stalevo 50, 75, 100, 125, 150, 200

–  Extended release capsules (combination levodopa formulation “beads”)

•  Rytary 23.75/95, 36.25/145, 48.75/195, 61.25/245 –  Enteral gel suspension delivered through PEG-J tube

•  Duopa – 2000 mg cartridges

Levodopa – most effective treatment – cannot substitute one formulation for another

Care Transitions into the care setting

At intake, it is Important to ask the patient/family the schedule and dosing interval (time between doses) for PD medications

• For dosing intervals, typical bid, tid, qid medication schedules are not typical for a person with Parkinson's • When entering medications into the electronic or paper record, specify PD med times to help ensure accurate schedules

•  With the patient/family, verify exact dosages and formulations (immediate release, controlled release, etc).

• Double check with medication bottles if possible

• Communicate this schedule to those who will be caring for the patient • Patient may need a dose of PD meds before meds are received from the pharmacy

• is there a way to accommodate this?

Care Transitions from the hospital • Check  the  discharge  summary  or  ask  the  pa<ent/family  about  medica<on  changes  made  in  the  hospital.      

• If  medica<ons  or  schedules  were  changed  during  hospitaliza<on  a  follow-­‐up  with  the  Neurologist  is  recommended    

Primary Problems of PD Care Management

▶  Lack of understanding of Parkinson’s disease – symptoms, treatment, etc.

▶  Lack of awareness about the critical importance of Parkinson’s medication timing

▶  Lack of awareness that many common medications for pain, nausea, depression, and psychosis are unsafe for people with Parkinson’s

▶  Hospital pharmacies that do not stock the full array of PD medications

▶  Lack of awareness that poorly-managed PD might result in mental confusion and other serious symptoms

Care considerations Observing for PD Med Side Effects

•  Balance medication effects and side effects

•  Dose-limiting side effects: • Nausea • Dyskinesia • Hallucinations • Orthostatic hypotension

Considerations for Care

▶  Take into consideration the time the last dose of levodopa was taken when considering cares, therapies and procedures. Allow for medications to “kick in”.

▶  If medications have to be crushed and administered through a tube, give them at least one hour prior to meals

▶  Dissolvable form of levodopa may be useful in some patients with swallowing difficulties

▶  Narcotics, muscle relaxants, bladder, sleep and pain medications can increase the risk of confusion, hallucinations or delirium

Other Potential Care Concerns – to be addressed in adapting your residence for PD

▶  Assisting mobility –  Addressing the environment for falls reduction

▶  Understanding mood changes ▶  Cognitive changes ▶  Coping with sleep changes ▶  Pain control ▶  Other

–  Constipation –  Bladder changes –  Skin changes

Thank you! Questions???

Joan Gardner RN BSN [email protected]


Top Related